世界のトリコモナス症治療薬市場予測2023-2029:メトロニダゾール、チニダゾール、セクニダゾール

【英語タイトル】Trichomoniasis Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23FB2518)・商品コード:MMG23FB2518
・発行会社(調査会社):Market Monitor Global
・発行日:2023年2月
・ページ数:119
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のトリコモナス症治療薬市場規模と予測を収録しています。・世界のトリコモナス症治療薬市場:売上、2018年-2023年、2024年-2029年
・世界のトリコモナス症治療薬市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のトリコモナス症治療薬市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「メトロニダゾール」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

トリコモナス症治療薬のグローバル主要企業は、Pfizer Inc.、Lupin Limited、Zydus Group、Teva Pharmaceuticals、Mission Pharmacal Company、Missionpharma A/S、Unique Pharmaceuticals Limited.、Alembic Pharmaceuticals Ltd、Bausch Health、Zauba Technologies & Data Services Private Limited、Glenmark Pharmaceuticals Inc、Edenbridge Pharmaceuticals, LLC、Aleor Dermaceuticals、Renhe Group、Xiuzheng Groupなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、トリコモナス症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のトリコモナス症治療薬市場:タイプ別、2018年-2023年、2024年-2029年
世界のトリコモナス症治療薬市場:タイプ別市場シェア、2022年
・メトロニダゾール、チニダゾール、セクニダゾール

世界のトリコモナス症治療薬市場:用途別、2018年-2023年、2024年-2029年
世界のトリコモナス症治療薬市場:用途別市場シェア、2022年
・病院薬局、オンライン薬局、小売薬局

世界のトリコモナス症治療薬市場:地域・国別、2018年-2023年、2024年-2029年
世界のトリコモナス症治療薬市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるトリコモナス症治療薬のグローバル売上、2018年-2023年
・主要企業におけるトリコモナス症治療薬のグローバル売上シェア、2022年
・主要企業におけるトリコモナス症治療薬のグローバル販売量、2018年-2023年
・主要企業におけるトリコモナス症治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Pfizer Inc.、Lupin Limited、Zydus Group、Teva Pharmaceuticals、Mission Pharmacal Company、Missionpharma A/S、Unique Pharmaceuticals Limited.、Alembic Pharmaceuticals Ltd、Bausch Health、Zauba Technologies & Data Services Private Limited、Glenmark Pharmaceuticals Inc、Edenbridge Pharmaceuticals, LLC、Aleor Dermaceuticals、Renhe Group、Xiuzheng Group

*************************************************************

・調査・分析レポートの概要
トリコモナス症治療薬市場の定義
市場セグメント
世界のトリコモナス症治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のトリコモナス症治療薬市場規模
世界のトリコモナス症治療薬市場規模:2022年 VS 2029年
世界のトリコモナス症治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのトリコモナス症治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のトリコモナス症治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:メトロニダゾール、チニダゾール、セクニダゾール
トリコモナス症治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:病院薬局、オンライン薬局、小売薬局
トリコモナス症治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別トリコモナス症治療薬市場規模 2022年と2029年
地域別トリコモナス症治療薬売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Pfizer Inc.、Lupin Limited、Zydus Group、Teva Pharmaceuticals、Mission Pharmacal Company、Missionpharma A/S、Unique Pharmaceuticals Limited.、Alembic Pharmaceuticals Ltd、Bausch Health、Zauba Technologies & Data Services Private Limited、Glenmark Pharmaceuticals Inc、Edenbridge Pharmaceuticals, LLC、Aleor Dermaceuticals、Renhe Group、Xiuzheng Group

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Trichomoniasis Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Trichomoniasis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Trichomoniasis Drug Overall Market Size
2.1 Global Trichomoniasis Drug Market Size: 2022 VS 2029
2.2 Global Trichomoniasis Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Trichomoniasis Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Trichomoniasis Drug Players in Global Market
3.2 Top Global Trichomoniasis Drug Companies Ranked by Revenue
3.3 Global Trichomoniasis Drug Revenue by Companies
3.4 Global Trichomoniasis Drug Sales by Companies
3.5 Global Trichomoniasis Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Trichomoniasis Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Trichomoniasis Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Trichomoniasis Drug Players in Global Market
3.8.1 List of Global Tier 1 Trichomoniasis Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Trichomoniasis Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Trichomoniasis Drug Market Size Markets, 2022 & 2029
4.1.2 Metronidazole
4.1.3 Tinidazole
4.1.4 Secnidazole
4.2 By Type – Global Trichomoniasis Drug Revenue & Forecasts
4.2.1 By Type – Global Trichomoniasis Drug Revenue, 2018-2023
4.2.2 By Type – Global Trichomoniasis Drug Revenue, 2024-2029
4.2.3 By Type – Global Trichomoniasis Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Trichomoniasis Drug Sales & Forecasts
4.3.1 By Type – Global Trichomoniasis Drug Sales, 2018-2023
4.3.2 By Type – Global Trichomoniasis Drug Sales, 2024-2029
4.3.3 By Type – Global Trichomoniasis Drug Sales Market Share, 2018-2029
4.4 By Type – Global Trichomoniasis Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Trichomoniasis Drug Market Size, 2022 & 2029
5.1.2 Hospital Pharmacy
5.1.3 Online Pharmacy
5.1.4 Retail Pharmacy
5.2 By Application – Global Trichomoniasis Drug Revenue & Forecasts
5.2.1 By Application – Global Trichomoniasis Drug Revenue, 2018-2023
5.2.2 By Application – Global Trichomoniasis Drug Revenue, 2024-2029
5.2.3 By Application – Global Trichomoniasis Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Trichomoniasis Drug Sales & Forecasts
5.3.1 By Application – Global Trichomoniasis Drug Sales, 2018-2023
5.3.2 By Application – Global Trichomoniasis Drug Sales, 2024-2029
5.3.3 By Application – Global Trichomoniasis Drug Sales Market Share, 2018-2029
5.4 By Application – Global Trichomoniasis Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Trichomoniasis Drug Market Size, 2022 & 2029
6.2 By Region – Global Trichomoniasis Drug Revenue & Forecasts
6.2.1 By Region – Global Trichomoniasis Drug Revenue, 2018-2023
6.2.2 By Region – Global Trichomoniasis Drug Revenue, 2024-2029
6.2.3 By Region – Global Trichomoniasis Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Trichomoniasis Drug Sales & Forecasts
6.3.1 By Region – Global Trichomoniasis Drug Sales, 2018-2023
6.3.2 By Region – Global Trichomoniasis Drug Sales, 2024-2029
6.3.3 By Region – Global Trichomoniasis Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Trichomoniasis Drug Revenue, 2018-2029
6.4.2 By Country – North America Trichomoniasis Drug Sales, 2018-2029
6.4.3 US Trichomoniasis Drug Market Size, 2018-2029
6.4.4 Canada Trichomoniasis Drug Market Size, 2018-2029
6.4.5 Mexico Trichomoniasis Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Trichomoniasis Drug Revenue, 2018-2029
6.5.2 By Country – Europe Trichomoniasis Drug Sales, 2018-2029
6.5.3 Germany Trichomoniasis Drug Market Size, 2018-2029
6.5.4 France Trichomoniasis Drug Market Size, 2018-2029
6.5.5 U.K. Trichomoniasis Drug Market Size, 2018-2029
6.5.6 Italy Trichomoniasis Drug Market Size, 2018-2029
6.5.7 Russia Trichomoniasis Drug Market Size, 2018-2029
6.5.8 Nordic Countries Trichomoniasis Drug Market Size, 2018-2029
6.5.9 Benelux Trichomoniasis Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Trichomoniasis Drug Revenue, 2018-2029
6.6.2 By Region – Asia Trichomoniasis Drug Sales, 2018-2029
6.6.3 China Trichomoniasis Drug Market Size, 2018-2029
6.6.4 Japan Trichomoniasis Drug Market Size, 2018-2029
6.6.5 South Korea Trichomoniasis Drug Market Size, 2018-2029
6.6.6 Southeast Asia Trichomoniasis Drug Market Size, 2018-2029
6.6.7 India Trichomoniasis Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Trichomoniasis Drug Revenue, 2018-2029
6.7.2 By Country – South America Trichomoniasis Drug Sales, 2018-2029
6.7.3 Brazil Trichomoniasis Drug Market Size, 2018-2029
6.7.4 Argentina Trichomoniasis Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Trichomoniasis Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Trichomoniasis Drug Sales, 2018-2029
6.8.3 Turkey Trichomoniasis Drug Market Size, 2018-2029
6.8.4 Israel Trichomoniasis Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Trichomoniasis Drug Market Size, 2018-2029
6.8.6 UAE Trichomoniasis Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Company Summary
7.1.2 Pfizer Inc. Business Overview
7.1.3 Pfizer Inc. Trichomoniasis Drug Major Product Offerings
7.1.4 Pfizer Inc. Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Inc. Key News & Latest Developments
7.2 Lupin Limited
7.2.1 Lupin Limited Company Summary
7.2.2 Lupin Limited Business Overview
7.2.3 Lupin Limited Trichomoniasis Drug Major Product Offerings
7.2.4 Lupin Limited Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.2.5 Lupin Limited Key News & Latest Developments
7.3 Zydus Group
7.3.1 Zydus Group Company Summary
7.3.2 Zydus Group Business Overview
7.3.3 Zydus Group Trichomoniasis Drug Major Product Offerings
7.3.4 Zydus Group Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.3.5 Zydus Group Key News & Latest Developments
7.4 Teva Pharmaceuticals
7.4.1 Teva Pharmaceuticals Company Summary
7.4.2 Teva Pharmaceuticals Business Overview
7.4.3 Teva Pharmaceuticals Trichomoniasis Drug Major Product Offerings
7.4.4 Teva Pharmaceuticals Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.4.5 Teva Pharmaceuticals Key News & Latest Developments
7.5 Mission Pharmacal Company
7.5.1 Mission Pharmacal Company Company Summary
7.5.2 Mission Pharmacal Company Business Overview
7.5.3 Mission Pharmacal Company Trichomoniasis Drug Major Product Offerings
7.5.4 Mission Pharmacal Company Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.5.5 Mission Pharmacal Company Key News & Latest Developments
7.6 Missionpharma A/S
7.6.1 Missionpharma A/S Company Summary
7.6.2 Missionpharma A/S Business Overview
7.6.3 Missionpharma A/S Trichomoniasis Drug Major Product Offerings
7.6.4 Missionpharma A/S Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.6.5 Missionpharma A/S Key News & Latest Developments
7.7 Unique Pharmaceuticals Limited.
7.7.1 Unique Pharmaceuticals Limited. Company Summary
7.7.2 Unique Pharmaceuticals Limited. Business Overview
7.7.3 Unique Pharmaceuticals Limited. Trichomoniasis Drug Major Product Offerings
7.7.4 Unique Pharmaceuticals Limited. Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.7.5 Unique Pharmaceuticals Limited. Key News & Latest Developments
7.8 Alembic Pharmaceuticals Ltd
7.8.1 Alembic Pharmaceuticals Ltd Company Summary
7.8.2 Alembic Pharmaceuticals Ltd Business Overview
7.8.3 Alembic Pharmaceuticals Ltd Trichomoniasis Drug Major Product Offerings
7.8.4 Alembic Pharmaceuticals Ltd Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.8.5 Alembic Pharmaceuticals Ltd Key News & Latest Developments
7.9 Bausch Health
7.9.1 Bausch Health Company Summary
7.9.2 Bausch Health Business Overview
7.9.3 Bausch Health Trichomoniasis Drug Major Product Offerings
7.9.4 Bausch Health Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.9.5 Bausch Health Key News & Latest Developments
7.10 Zauba Technologies & Data Services Private Limited
7.10.1 Zauba Technologies & Data Services Private Limited Company Summary
7.10.2 Zauba Technologies & Data Services Private Limited Business Overview
7.10.3 Zauba Technologies & Data Services Private Limited Trichomoniasis Drug Major Product Offerings
7.10.4 Zauba Technologies & Data Services Private Limited Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.10.5 Zauba Technologies & Data Services Private Limited Key News & Latest Developments
7.11 Glenmark Pharmaceuticals Inc
7.11.1 Glenmark Pharmaceuticals Inc Company Summary
7.11.2 Glenmark Pharmaceuticals Inc Trichomoniasis Drug Business Overview
7.11.3 Glenmark Pharmaceuticals Inc Trichomoniasis Drug Major Product Offerings
7.11.4 Glenmark Pharmaceuticals Inc Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.11.5 Glenmark Pharmaceuticals Inc Key News & Latest Developments
7.12 Edenbridge Pharmaceuticals, LLC
7.12.1 Edenbridge Pharmaceuticals, LLC Company Summary
7.12.2 Edenbridge Pharmaceuticals, LLC Trichomoniasis Drug Business Overview
7.12.3 Edenbridge Pharmaceuticals, LLC Trichomoniasis Drug Major Product Offerings
7.12.4 Edenbridge Pharmaceuticals, LLC Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.12.5 Edenbridge Pharmaceuticals, LLC Key News & Latest Developments
7.13 Aleor Dermaceuticals
7.13.1 Aleor Dermaceuticals Company Summary
7.13.2 Aleor Dermaceuticals Trichomoniasis Drug Business Overview
7.13.3 Aleor Dermaceuticals Trichomoniasis Drug Major Product Offerings
7.13.4 Aleor Dermaceuticals Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.13.5 Aleor Dermaceuticals Key News & Latest Developments
7.14 Renhe Group
7.14.1 Renhe Group Company Summary
7.14.2 Renhe Group Business Overview
7.14.3 Renhe Group Trichomoniasis Drug Major Product Offerings
7.14.4 Renhe Group Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.14.5 Renhe Group Key News & Latest Developments
7.15 Xiuzheng Group
7.15.1 Xiuzheng Group Company Summary
7.15.2 Xiuzheng Group Business Overview
7.15.3 Xiuzheng Group Trichomoniasis Drug Major Product Offerings
7.15.4 Xiuzheng Group Trichomoniasis Drug Sales and Revenue in Global (2018-2023)
7.15.5 Xiuzheng Group Key News & Latest Developments
8 Global Trichomoniasis Drug Production Capacity, Analysis
8.1 Global Trichomoniasis Drug Production Capacity, 2018-2029
8.2 Trichomoniasis Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Trichomoniasis Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Trichomoniasis Drug Supply Chain Analysis
10.1 Trichomoniasis Drug Industry Value Chain
10.2 Trichomoniasis Drug Upstream Market
10.3 Trichomoniasis Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Trichomoniasis Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Trichomoniasis Drug in Global Market
Table 2. Top Trichomoniasis Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Trichomoniasis Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Trichomoniasis Drug Revenue Share by Companies, 2018-2023
Table 5. Global Trichomoniasis Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Trichomoniasis Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Trichomoniasis Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Trichomoniasis Drug Product Type
Table 9. List of Global Tier 1 Trichomoniasis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Trichomoniasis Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Trichomoniasis Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Trichomoniasis Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Trichomoniasis Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Trichomoniasis Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Trichomoniasis Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Trichomoniasis Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Trichomoniasis Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Trichomoniasis Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Trichomoniasis Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Trichomoniasis Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Trichomoniasis Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Trichomoniasis Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Trichomoniasis Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Trichomoniasis Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Trichomoniasis Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Trichomoniasis Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Trichomoniasis Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Trichomoniasis Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Trichomoniasis Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Trichomoniasis Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Trichomoniasis Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Trichomoniasis Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Trichomoniasis Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Trichomoniasis Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Trichomoniasis Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Trichomoniasis Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Trichomoniasis Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Trichomoniasis Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Trichomoniasis Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Trichomoniasis Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Trichomoniasis Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Trichomoniasis Drug Sales, (K Units), 2024-2029
Table 46. Pfizer Inc. Company Summary
Table 47. Pfizer Inc. Trichomoniasis Drug Product Offerings
Table 48. Pfizer Inc. Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Pfizer Inc. Key News & Latest Developments
Table 50. Lupin Limited Company Summary
Table 51. Lupin Limited Trichomoniasis Drug Product Offerings
Table 52. Lupin Limited Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Lupin Limited Key News & Latest Developments
Table 54. Zydus Group Company Summary
Table 55. Zydus Group Trichomoniasis Drug Product Offerings
Table 56. Zydus Group Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Zydus Group Key News & Latest Developments
Table 58. Teva Pharmaceuticals Company Summary
Table 59. Teva Pharmaceuticals Trichomoniasis Drug Product Offerings
Table 60. Teva Pharmaceuticals Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Teva Pharmaceuticals Key News & Latest Developments
Table 62. Mission Pharmacal Company Company Summary
Table 63. Mission Pharmacal Company Trichomoniasis Drug Product Offerings
Table 64. Mission Pharmacal Company Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Mission Pharmacal Company Key News & Latest Developments
Table 66. Missionpharma A/S Company Summary
Table 67. Missionpharma A/S Trichomoniasis Drug Product Offerings
Table 68. Missionpharma A/S Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Missionpharma A/S Key News & Latest Developments
Table 70. Unique Pharmaceuticals Limited. Company Summary
Table 71. Unique Pharmaceuticals Limited. Trichomoniasis Drug Product Offerings
Table 72. Unique Pharmaceuticals Limited. Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Unique Pharmaceuticals Limited. Key News & Latest Developments
Table 74. Alembic Pharmaceuticals Ltd Company Summary
Table 75. Alembic Pharmaceuticals Ltd Trichomoniasis Drug Product Offerings
Table 76. Alembic Pharmaceuticals Ltd Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Alembic Pharmaceuticals Ltd Key News & Latest Developments
Table 78. Bausch Health Company Summary
Table 79. Bausch Health Trichomoniasis Drug Product Offerings
Table 80. Bausch Health Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Bausch Health Key News & Latest Developments
Table 82. Zauba Technologies & Data Services Private Limited Company Summary
Table 83. Zauba Technologies & Data Services Private Limited Trichomoniasis Drug Product Offerings
Table 84. Zauba Technologies & Data Services Private Limited Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Zauba Technologies & Data Services Private Limited Key News & Latest Developments
Table 86. Glenmark Pharmaceuticals Inc Company Summary
Table 87. Glenmark Pharmaceuticals Inc Trichomoniasis Drug Product Offerings
Table 88. Glenmark Pharmaceuticals Inc Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Glenmark Pharmaceuticals Inc Key News & Latest Developments
Table 90. Edenbridge Pharmaceuticals, LLC Company Summary
Table 91. Edenbridge Pharmaceuticals, LLC Trichomoniasis Drug Product Offerings
Table 92. Edenbridge Pharmaceuticals, LLC Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Edenbridge Pharmaceuticals, LLC Key News & Latest Developments
Table 94. Aleor Dermaceuticals Company Summary
Table 95. Aleor Dermaceuticals Trichomoniasis Drug Product Offerings
Table 96. Aleor Dermaceuticals Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Aleor Dermaceuticals Key News & Latest Developments
Table 98. Renhe Group Company Summary
Table 99. Renhe Group Trichomoniasis Drug Product Offerings
Table 100. Renhe Group Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Renhe Group Key News & Latest Developments
Table 102. Xiuzheng Group Company Summary
Table 103. Xiuzheng Group Trichomoniasis Drug Product Offerings
Table 104. Xiuzheng Group Trichomoniasis Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Xiuzheng Group Key News & Latest Developments
Table 106. Trichomoniasis Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 107. Global Trichomoniasis Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 108. Global Trichomoniasis Drug Production by Region, 2018-2023 (K Units)
Table 109. Global Trichomoniasis Drug Production by Region, 2024-2029 (K Units)
Table 110. Trichomoniasis Drug Market Opportunities & Trends in Global Market
Table 111. Trichomoniasis Drug Market Drivers in Global Market
Table 112. Trichomoniasis Drug Market Restraints in Global Market
Table 113. Trichomoniasis Drug Raw Materials
Table 114. Trichomoniasis Drug Raw Materials Suppliers in Global Market
Table 115. Typical Trichomoniasis Drug Downstream
Table 116. Trichomoniasis Drug Downstream Clients in Global Market
Table 117. Trichomoniasis Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Trichomoniasis Drug Segment by Type in 2022
Figure 2. Trichomoniasis Drug Segment by Application in 2022
Figure 3. Global Trichomoniasis Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Trichomoniasis Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Trichomoniasis Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Trichomoniasis Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Trichomoniasis Drug Revenue in 2022
Figure 9. By Type - Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Trichomoniasis Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Trichomoniasis Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Trichomoniasis Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Trichomoniasis Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 23. US Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 28. Germany Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 37. China Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 44. Brazil Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Trichomoniasis Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Trichomoniasis Drug Sales Market Share, 2018-2029
Figure 48. Turkey Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Trichomoniasis Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Trichomoniasis Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Trichomoniasis Drug by Region, 2022 VS 2029
Figure 54. Trichomoniasis Drug Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のトリコモナス症治療薬市場予測2023-2029:メトロニダゾール、チニダゾール、セクニダゾール] (コード:MMG23FB2518)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトリコモナス症治療薬市場予測2023-2029:メトロニダゾール、チニダゾール、セクニダゾール]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆